MedTrace Logo

Metacognitive Therapy for Obsessive-Compulsive Disorder

NCT02867449 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2021-09-28

No results posted yet for this study

Summary

Cognitive behavior therapy is the most effective treatment of obsessive-compulsive disorder. However, the majority of treated patients remain symptomatic. The metacognitive therapy by Wells (1997) could achieve substantial gains in first pilot studies. The purpose of this study is to investigate this approach with a randomized controlled trial by comparing metacognitive therapy with exposure and response prevention for obsessive-compulsive disorder.

Conditions

  • Obsessive-Compulsive Disorder (OCD)

Interventions

BEHAVIORAL

Metacognitive Therapy

Metacognitive Therapy for OCD according to Wells (1997)

BEHAVIORAL

Exposure and Response Prevention

Exposure and Response Prevention for OCD according to Kozak \& Foa (1997)

Sponsors & Collaborators

  • Philipps University Marburg

    collaborator OTHER

  • German Research Foundation

    collaborator OTHER

  • University of Leipzig

    lead OTHER

Principal Investigators

  • Cornelia Exner, Prof. Dr. · Leipzig University

  • Julia A. Glombiewski, Dr. · Philipps University Marburg

  • Alexandra Kleiman, Dr. · Leipzig University

  • Anke Haberkamp, Dr. · Philipps University Marburg

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2020-01-31
Completion
2020-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02867449 on ClinicalTrials.gov